RICHMOND, Calif.--Onyx Pharmaceuticals and the Lawrence Livermore National Laboratory will collaborate on developing a functional genomics system that can be used in expressing, purifying, and characterizing the components of the majority of proteins expressed in humans, known as the human proteome. Information gained on the human proteome will be used in determining the function of genes that encode the proteins, aiding in the understanding of the human genome.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.